Last June, several NYUCI physicians made presentations on the treatment of cancers such as melanoma, gastrointestinal cancers, and pediatric leukemia at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) - the world's leading society for professionals specializing in cancer care. ASCO boasts a roster of more than 20,000 members from the United States and abroad. Its Annual Meeting, considered to be the premier scientific and educational meeting for oncology professionals, attracts more than 25,000 each year and provides an international forum for the presentation of the most current research and advances in cancer treatment and care.
David Fishman, MD, Professor of Obstetrics and Gynecology and Director of Gynecologic Oncology, Cancer Prevention and Early Detection, received a certificate of recognition from the National Cancer Institute for his pioneering work on the early detection of ovarian cancer. He has combined clinical genetics, proteomics, and molecular and cell biology to improve patient care. Dr. Fishman leads NYU's 100 Women in Hedge Funds National Ovarian Cancer Early Detection Program, whose goal is to identify women who have an increased risk of ovarian cancer by pinpointing highly sensitive and specific "tumor markers" - proteins that signal the presence of early-stage ovarian cancer. The program also received a $206,000 contribution from a fundraising event organized by Mark Fishman and Sal Naro of Sailfish Capital.
Medical oncologist Deirdre Cohen, MD has joined the Gastrointestinal Oncology team at the NYU Cancer Institute. Dr. Cohen, who was previously a fellow in Medical Oncology/Hematology at NYU Medical Center, will contribute to the NYU Cancer Institute's growth by designing and implementing new clinical trials related to gastrointestinal cancers. She was a recent ASCO Foundation Gastrointestinal Merit Award winner for her abstract on Gastric Cancer and Intraperitoneal Chemotherapy. Dr. Cohen graduated from medical school at SUNY Downstate Medical Center in Brooklyn and completed her residency training in Internal Medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center.
Team Continuum has pledged $1 million over four years to the NYU Cancer Institute to create an Early-Stage Clinical Trials Unit. Team Continuum raises funds to provide immediate help to cancer patients being treated in New York's cancer treatment centers. The group also advocates for cancer patients to join support groups and play an active role in their treatment. Team Continuum - which includes patients, doctors, and nurses - runs marathons to raise awareness and funding for patient-care programs.
A golf outing organized by Douglas Myers has raised some $20,000 to support the Melanoma Research Fund at the NYU Cancer Institute. The Strategies for Wealth Golf Outing took place in June at the Century Country Club in Purchase, New York. We thank Mr. Myers for his efforts and generosity.
Download the Fall 2007 Newsletter (pdf)
